Neximmune (NEXI) Stock Price

Neximmune Price

NASDAQ·CLOSED
0.00USD+0.00 (+0.00 %)
Market closed

Analysts set a median price target of 2.04 USD, implying 2,039,900.1% above the current price. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus. Over the past year Neximmune shares have gained 200.0%. The stock trades about 500% above its 52-week low.

Neximmune stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Neximmune over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Neximmune stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Neximmune's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Neximmune Stock Price History
DateNeximmune Price
8/12/20260.00 USD
8/11/20260.00 USD
8/10/20260.00 USD
8/7/20260.00 USD
8/6/20260.00 USD
8/5/20260.00 USD
8/4/20260.00 USD
8/3/20260.00 USD
7/30/20260.00 USD
7/29/20260.00 USD
7/28/20260.00 USD
7/27/20260.00 USD
7/24/20260.00 USD
7/23/20260.00 USD
7/22/20260.00 USD
7/21/20260.00 USD
7/20/20260.00 USD
7/17/20260.00 USD
7/16/20260.00 USD
7/15/20260.00 USD
7/14/20260.00 USD
7/13/20260.00 USD
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/3/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/19/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
5/6/20260.00 USD
5/5/20260.00 USD
5/4/20260.00 USD
5/1/20260.00 USD
4/30/20260.00 USD
4/29/20260.00 USD
4/28/20260.00 USD
4/27/20260.00 USD
4/24/20260.00 USD
4/23/20260.00 USD
4/22/20260.00 USD
4/21/20260.00 USD
4/20/20260.00 USD
4/17/20260.00 USD
4/16/20260.00 USD
4/15/20260.00 USD
4/14/20260.00 USD
4/13/20260.00 USD
4/10/20260.00 USD
4/9/20260.00 USD
4/8/20260.00 USD
4/7/20260.00 USD
4/6/20260.00 USD
4/2/20260.00 USD
4/1/20260.00 USD
3/31/20260.00 USD
3/30/20260.00 USD
3/27/20260.00 USD
3/26/20260.00 USD
3/25/20260.00 USD
3/24/20260.00 USD
3/23/20260.00 USD
3/20/20260.00 USD
3/19/20260.00 USD
3/18/20260.00 USD
3/17/20260.00 USD
3/16/20260.00 USD
3/13/20260.00 USD
3/12/20260.00 USD
3/11/20260.00 USD
3/10/20260.00 USD
3/9/20260.00 USD
3/6/20260.00 USD
3/5/20260.00 USD
3/4/20260.00 USD
3/3/20260.00 USD
3/2/20260.00 USD
2/27/20260.00 USD
2/26/20260.00 USD
2/25/20260.00 USD
2/24/20260.00 USD
2/23/20260.00 USD
2/20/20260.00 USD
2/19/20260.00 USD
2/18/20260.00 USD
2/17/20260.00 USD
2/13/20260.00 USD
2/12/20260.00 USD
2/11/20260.00 USD
2/10/20260.00 USD
2/9/20260.00 USD
2/6/20260.00 USD
2/5/20260.00 USD
2/4/20260.00 USD
2/3/20260.00 USD
2/2/20260.00 USD
1/30/20260.00 USD
1/29/20260.00 USD
1/28/20260.00 USD
1/27/20260.00 USD
1/26/20260.00 USD
1/23/20260.00 USD
1/22/20260.00 USD
1/21/20260.00 USD
1/20/20260.00 USD
1/16/20260.00 USD
1/15/20260.00 USD
1/14/20260.00 USD
1/13/20260.00 USD
1/12/20260.00 USD
1/9/20260.00 USD
1/8/20260.00 USD
1/7/20260.00 USD
1/6/20260.00 USD
1/5/20260.00 USD
1/2/20260.00 USD
12/31/20250.00 USD
12/30/20250.00 USD
12/29/20250.00 USD
12/26/20250.00 USD
12/24/20250.00 USD
12/23/20250.00 USD
12/22/20250.00 USD
12/19/20250.00 USD
12/18/20250.00 USD
12/17/20250.00 USD
12/16/20250.00 USD
12/15/20250.00 USD
12/12/20250.00 USD
12/11/20250.00 USD
12/10/20250.00 USD
12/9/20250.00 USD
12/8/20250.00 USD
12/5/20250.00 USD
12/4/20250.00 USD
12/3/20250.00 USD
12/2/20250.00 USD
12/1/20250.00 USD
11/28/20250.00 USD
11/26/20250.00 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.00 USD
9/24/20250.00 USD
9/23/20250.00 USD
9/22/20250.00 USD
9/19/20250.00 USD
9/18/20250.00 USD
9/17/20250.00 USD
9/16/20250.00 USD
9/15/20250.00 USD
9/12/20250.00 USD
9/11/20250.00 USD
9/10/20250.00 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
8/21/20250.00 USD
8/20/20250.00 USD
8/19/20250.00 USD
8/18/20250.00 USD
8/15/20250.00 USD
8/14/20250.00 USD
Access this data via the Eulerpool API

Neximmune Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
0.00 USD
-13.24 M USD
-14.91 M USD
Jan 1, 2019
0.00 USD
-20.89 M USD
-23.21 M USD
Jan 1, 2020
0.00 USD
-27.85 M USD
-33.15 M USD
Jan 1, 2021
0.00 USD
-53.25 M USD
-51.28 M USD
Jan 1, 2022
0.00 USD
-63.08 M USD
-62.51 M USD
Jan 1, 2023 (e)
0.00 USD
-34.08 M USD
-907,392.00 USD
Jan 1, 2024 (e)
0.00 USD
-29.18 M USD
-212,670.00 USD
Jan 1, 2025 (e)
0.00 USD
-23.45 M USD
-127,602.00 USD

Neximmune Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 12:30 PM
 
EBITM USD
NET INCOMEM USD
NET INCOME GROWTH%
SHARESk
201820192020202120222023e2024e2025e
-13.00-20.00-27.00-53.00-63.00-34.00-29.00-23.00
-14.00-23.00-33.00-51.00-62.00
64.2943.4854.5521.57
860.00860.00860.00810.00960.00960.00960.00960.00
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Neximmune generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Neximmune retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Neximmune's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Neximmune has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Neximmune's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Neximmune stock margins

The Neximmune margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Neximmune. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Neximmune.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
0.00 %
- %
- %
Jan 1, 2019
0.00 %
- %
- %
Jan 1, 2020
0.00 %
- %
- %
Jan 1, 2021
0.00 %
- %
- %
Jan 1, 2022
0.00 %
- %
- %
Jan 1, 2023 (e)
0.00 %
- %
- %
Jan 1, 2024 (e)
0.00 %
- %
- %
Jan 1, 2025 (e)
0.00 %
- %
- %

Neximmune Stock Revenue, EBIT, Earnings per Share

The Neximmune earnings per share therefore indicates how much revenue Neximmune has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 USD
-384.88 USD
-433.43 USD
Jan 1, 2019
0.00 USD
-607.27 USD
-674.71 USD
Jan 1, 2020
0.00 USD
-809.59 USD
-963.66 USD
Jan 1, 2021
0.00 USD
-1,643.52 USD
-1,582.72 USD
Jan 1, 2022
0.00 USD
-1,642.71 USD
-1,627.86 USD
Jan 1, 2023 (e)
0.00 USD
-887.56 USD
-16.32 USD
Jan 1, 2024 (e)
0.00 USD
-759.85 USD
-3.82 USD
Jan 1, 2025 (e)
0.00 USD
-610.78 USD
-2.30 USD

Neximmune business model & stock analysis

Neximmune Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Neximmune historical P/E ratio, EBIT multiple, and P/S ratio

Neximmune annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Neximmune shares outstanding

The number of shares of Neximmune was 38,400 in 2025. This indicates how many shares Neximmune is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
34,400.00 Stocks
Jan 1, 2019
34,400.00 Stocks
Jan 1, 2020
34,400.00 Stocks
Jan 1, 2021
32,400.00 Stocks
Jan 1, 2022
38,400.00 Stocks
Jan 1, 2023 (e)
38,400.00 Stocks
Jan 1, 2024 (e)
38,400.00 Stocks
Jan 1, 2025 (e)
38,400.00 Stocks

Neximmune stock splits

In Neximmune's history, there have been no stock splits.

Current Neximmune forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
75.00 % (6)
Hold
25.00 % (2)
Sell
0.00 % (0)
12M Price Target
2.04
Last Price
0.00
Currency
USD
12M Return Potential
2,039,900.05 %
LTM Return
0 %

Neximmune Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
3/26/2024-1.53USD-0.00USD-2023 Q4
11/13/2023-0.26USD-0.00USD-2023 Q3
8/14/2023-0.34USD-0.00USD-2023 Q2
11/14/2022-0.71USD-0.00USD-2022 Q3

Neximmune shareholder structure

% Name
0.00000%
BNP Paribas Securities Corp. North America
BNP Paribas Securities Corp. North America
0.00000%
BofA Global Research (US)
BofA Global Research (US)
0.00000%
Comerica, Inc.
Comerica, Inc.
0.00000%
EPIQ Capital Group, LLC
EPIQ Capital Group, LLC
0.00000%
J.P. Morgan Securities LLC
J.P. Morgan Securities LLC
0.00000%
PNC Investments LLC
PNC Investments LLC

Neximmune Executives and Management Board

1 members · avg. age 63 · 0 % women

CJ

Mr. Craig Jalbert (63)

President, Chief Executive Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary, Director · since 2024

Frequently asked questions about Neximmune

Analysts currently set an average price target of 2.04 USD for the Neximmune stock (median: 2.04 USD), implying +2.0 M % versus the latest price. The consensus is based on 8 analyst ratings.

7 analysts currently rate the Neximmune stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Neximmune share trades at 0.00 EUR (0.00 USD).

The Neximmune share (NEXI) is listed on 3 stock exchanges, including: NASDAQ (NEXI), Frankfurt (7370.F), München (7370.MU).

No history available for Neximmune.

The revenue cannot currently be calculated for Neximmune.

The profit cannot currently be calculated for Neximmune.

The P/E ratio cannot be calculated for Neximmune at the moment.

The P/S cannot be calculated for Neximmune currently.

The Eulerpool Quality Score for Neximmune is 2/10.

The ISIN of Neximmune is US65344D2080. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Neximmune is A3EUTV. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Neximmune is NEXI. The ticker symbol is used to trade Neximmune shares on the stock exchange.

Neximmune paid dividends every year for the past 0 years.

Neximmune is assigned to the 'Health' sector.

The dividends of Neximmune are distributed in USD.

All fundamentals and in-depth analysis of Neximmune

Our stock analysis for Neximmune stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Neximmune. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.